Acquiring Company
medimaps group S.A
Acquired Company
Radiobotics ApS
Description
Medimaps Group S.A. and Radiobotics ApS have announced a strategic merger aimed at expanding their AI-driven musculoskeletal imaging portfolio. This merger will combine their technologies and expertise to create a comprehensive suite of solutions for fracture detection and risk prediction. The new entity will leverage clinical expertise to improve accessibility across 90 markets worldwide.
Who to call at medimaps group S.A, and when
When medimaps group S.A changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day medimaps group S.A raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at medimaps group S.A, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment medimaps group S.A makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Radiobotics ApS?
Radiobotics ApS was acquired by medimaps group S.A, based in Geneva. The deal was reported on March 2, 2026. Medimaps is a leading provider of AI-driven imaging solutions for bone microarchitecture worldwide. medimaps group S.A is privately held and operates in Manufacturing.
When did medimaps group S.A acquire Radiobotics ApS?
medimaps group S.A's acquisition of Radiobotics ApS was reported on March 2, 2026. Medimaps Group S.A. and Radiobotics ApS have announced a strategic merger aimed at expanding their AI-driven musculoskeletal imaging portfolio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Radiobotics ApS do?
Radiobotics ApS is a leader in AI-powered musculoskeletal radiology solutions. The company focuses on enhancing clinical workflows and patient outcomes in MSK imaging. Their primary offering is RBfracture™, designed for trauma-related findings. It is privately held, operating in Biotechnology, and is based in Copenhagen.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.